Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2581 to 2595 of 7685 results

  1. Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment ID6474

    In development [GID-TA11613] Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Artificial intelligence technologies to aid the opportunistic detection of vertebral fragility fractures on radiographic images

    Awaiting development [GID-HTE10059] Expected publication date: 20 August 2025

    Health technology evaluations
    Awaiting development

  3. Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable ID3981

    In development [GID-TA10912] Expected publication date: 18 June 2025

    Technology appraisal guidance
    In development

  4. Tobacco: preventing uptake, promoting quitting and treating dependence - Cytisine for smoking cessation

    In development [GID-NG10427] Expected publication date: 04 February 2025

    NICE guideline
    In development

  5. Cemiplimab with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer [ID3949]

    In development [GID-TA10907] Expected publication date: 30 April 2025

    Technology appraisal guidance
    In development

  6. Tobacco: preventing uptake, promoting quitting and treating dependence - Cytisine for smoking cessation: draft guidance consultation

    We are listening to your views on this NICE guideline. Comments close 29 November 2024.

    NICE guideline
    In consultation

  7. Pulsed field ablation for atrial fibrillation

    In development [GID-IPG10267] Expected publication date: 14 August 2025

    Interventional procedures guidance
    In development

  8. Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasia

    In development [GID-IPG10268] Expected publication date: 08 January 2025

    Interventional procedures guidance
    In development

  9. Noninvasive Vagus Nerve Stimulation For reactive airway disease

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  10. Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)

    In development [GID-NG10216] Expected publication date: TBC

    NICE guideline
    In development

  11. Biomarker tests to help diagnose preterm labour in women with intact membranes (DG33)

    Evidence-based recommendations on biomarker tests to help diagnose preterm labour in women with intact membranes. The tests are Actim Partus, PartoSure and the Rapid fetal fibronectin (fFN) 10Q Cassette Kit (at thresholds other than 50 nanograms/millilitre)

    Diagnostics guidance
    Published
    4 July 2018
    View recommendations

    Sections for DG33

  12. Dostarlimab with platinum-based chemotherapy for advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency ID6415

    In development [GID-TA11503] Expected publication date: 10 September 2025

    Technology appraisal guidance
    In development

  13. Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389]

      Status ...

    Technology appraisal guidance
    Topic selection

  14. Triheptanoin for treating long-chain fatty acid oxidation disorders ID3891

    In development [GID-TA11473] Expected publication date: TBC

    Technology appraisal guidance
    In development

  15. Seladelpar for previously treated primary biliary cholangitis ID6429

    In development [GID-TA11540] Expected publication date: 10 September 2025

    Technology appraisal guidance
    In development